
In part 2, Neal Cooper and Matt Sample address the foreseeable challenges and necessary questions surrounding the FDA’s push toward 12-digit national drug codes.

In part 2, Neal Cooper and Matt Sample address the foreseeable challenges and necessary questions surrounding the FDA’s push toward 12-digit national drug codes.

Chad Worz, PharmD, BCGP, FASCP, and Jeffrey Hogan, present on the implications behind major PBM reform signed in February and how the reimbursement landscape is expected to shift.

Non-high-density lipoprotein cholesterol matters in type 2 diabetes care and can be managed with statins, combination therapy, and omega‑3s.

Meta-analysis shows PCV13 followed by PPSV23 boosts pneumococcal immunity in seniors without added adverse effects.

This decision marks a historic milestone as sparsentan becomes the first and only medication specifically approved for this rare and devastating condition.

Pharmacists can help cut prescription abandonment with proactive benefit checks, prior authorization help, and copay assistance.

Pharmacists can help to choose the right ingredient and avoid drug interactions for OTC relief for gas, motion sickness, nausea, and heartburn.

FDA-approved atrasentan cuts proteinuria in IgA nephropathy, with ALIGN trial results, safety insights, and dosing cautions.

Tentative FDA nod for generic semaglutide signals more glucagon-like peptide-1 access, easing pharmacy hurdles and curbing risky compounded alternatives.

Meta-analysis shows CGM lowers HbA1c and hypoglycemia in insulin-treated type 2 diabetes, while pharmacists tackle training, costs, and skin issues.

Researchers assess medication adherence across initial combination therapy users during their first year of type 2 diabetes treatment.

Social determinants of health shape pneumococcal risk, making vaccination especially important for specific populations.

With persistent challenges in the arena of US maternal health care, researchers assess pharmacists’ knowledge, confidence, and perceived barriers in filling maternal health gaps.

Pharmacists expand vaccine access, but billing rules, payer barriers, and uneven reimbursement keep immunization services from scaling nationwide.

Lunsekimig cuts asthma exacerbations and boosts lung function while improving nasal polyps—an emerging dual-target biologic for respiratory care.

As debates heat up between anti-abortion and pro-life advocates, the federal government places a hold on any action toward mifepristone’s approval.

Community pharmacists weave brief lifestyle coaching and point-of-care testing into medication management, improving diabetes and hypertension outcomes.

New evidence links poor sleep and diabetes risk to widespread prenatal anxiety, urging pharmacists to support metabolic control and mental health.

In part 2 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explored the modernization behind his organization’s newly introduced ‘hybrid pharmacist’ role.

In response to evolving serotypes and vaccine guidance, researchers assess the most effective pneumococcal vaccination strategies across Taiwan.

A veteran pharmacist launches a cost-plus, cash-only Rhode Island pharmacy, featuring AI ordering, pet medications, and CLIA testing to boost access.

Self-regulating hydrogel speeds diabetic foot ulcer healing, cutting wound area 94% in 4 weeks through smart pH-guided ion release.

Researchers aim to update and expand on register-based surveillance of severe acute respiratory infections related to Streptococcus pneumoniae in Denmark.

Combining medical, rehab, psychological, and complementary therapies offers more person-centered relief for chronic pain.

Emily Eddy, PharmD, BCACP, BC-ADM, CDCES, presents on the ever-expanding world of glucagon-like peptide-1s, now heading toward indications for chronic kidney disease and substance use disorder.

Pharmacists face alarming burnout rates, but hobbies—from horses to sports—can help protect mental health and keep patient care safer.

Local pharmacies deliver rapid flu, COVID-19, strep, and urinary tract infection tests with same-day treatment, easing access gaps and cutting urgent care costs.

Investigators of the multicenter cohort aim to determine if the 13-valent pneumococcal conjugate vaccine impacted disease activity over a 24-month period.

A growing body of evidence suggests that the choice of glucose-lowering therapy may play a critical role in colorectal cancer prevention.

Ulcers represent one of the most serious and costly complications of diabetes characterized by a high risk of recurrence.